Atlas Trials

Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer

Clinical trial NCT02117817 · WITHDRAWN

Trial details

NCT number
NCT02117817
Sponsor
Rutgers, The State University of New Jersey
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian CancerEndometrial CancerRecurrent Ovarian CancerRecurrent Endometrial Cancer
Start date
2015-02-01
Primary completion
2015-02-25
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.